JLL UK Clustering Insights

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Sarah Haywood, Managing Director of Advanced Oxford. Dive into the latest developments in Oxfordshire's science and technology landscape and discover the opportunities and challenges shaping the region's growth and innovation.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Olivia Drew, Portfolio Manager, UK Life Sciences at UBS as they discuss the opportunities across the UK and European market and why Life Sciences needs to be considered as a global sector for investment.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Professor Greg Clark, Chair of Connected Places Catapult and 3Ci. This episode delves into the role of innovation districts and the innovation economy's role in shaping the future of urbanisation as we continue to experience population growth and the drive to meet future sustainability requirements of the planet.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Hugo Villanueva, VC Investor at Octopus Ventures. The episode explores the opportunities for Life Sciences companies to gain venture capital funding but also, why social value is critical in driving success within the Life Sciences sector.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Jason Mellad, Co-Founder & CEO of Startcodon. This episode looks at the opportunities for scaling Life Sciences businesses to gain venture capital backing and the opportunities across the UK to bridge the gap between start-ups and value-add investors.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Harriet Fear MBE, Managing Director at Cambridge&.

This episode looks at how can the UK, especially Cambridge as part of the Golden Triangle retain its position as a world-leading centre for innovation. And how can the real estate sector meet the evolving needs of the Life Sciences industry when space is becoming increasingly limited?

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Kasia Averall, Head of Clusters at Cell and Gene Therapy Catapult.

In the podcast, they discuss a range of topics affecting the life sciences sector in the UK, from how to ensure your lab space is built and designed for innovation to thrive to the challenges in future-proofing a facility without knowing what the future may be. They also explore the requirements needed for GMP manufacturing space versus your traditional R&D space, and how you meet the regulatory requirements which accompany this.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Toby Reid, Executive Director at Pioneer Group, a company that helps build and operate life science campuses to help high-tech businesses thrive.

In the podcast they discuss a range of topics affecting the life sciences sector in the UK, from what makes a successful innovation ecosystem to how to build a flexible space in a market that’s changing at pace. They also debate which is more important in the real estate decision-making process – rental values or access to talent, and whether we can expect the UK market to remain a science and technology superpower post-Brexit.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Tony Jones, CEO of One Nucleus, the not-for-profit Life Sciences & Healthcare membership organisation.

In the podcast they discuss a range of topics affecting the life sciences sector in the UK, from how destination real estate locations can enable innovation and attract the best talent, to the pivotal role the government plays in the UK’s knowledge economy.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by John O’Driscoll, Global CIO & Head of Investment at AXA Investment Managers – Real Assets.

In the podcast they discuss AXA IM’s ambition and vision in the life sciences sector, focusing specifically on how ESG and societal benefit are key drivers in their investment decisions.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Michael Skynner, Chief Technology Officer, and Richard Hughes, VP of IT, Informatics & Facilities, at Bicycle Therapeutics.

In the podcast they discuss how the demand profile of life science companies changes as their businesses mature, and how real estate decisions are now primarily based on the desires and needs of employees in the post-pandemic world.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Neelam Patel, CEO of MedCity, the life sciences cluster organisation for London, which plays a pivotal role in bridging industry, NHS and academia to boost innovation and economic growth. In the podcast they discuss the challenges facing the life sciences industry from the point of view of the supply and demand of real estate – and explore some of the solutions MedCity are currently working on to help solve the problem, both in London and beyond.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Stanhope’s Charles Walford, Development Director & Head of Life Sciences, to discuss Stanhope’s approach to the occupier market in the Life Sciences sector. With space at a premium in London and the Golden Triangle, they delve into what the emerging trends are – and how those trends influence both design and the provision of space in this competitive market.

“Today’s science deserves a better lab; we got tired of waiting so

we created it”. In our latest podcast, Chris Walters, JLL’s Head of UK Life

Sciences, is joined by SmartLabs’ Amrit Chauduri, CEO, to discuss how and why

SmartLabs was created in the US. With flexibility of lab space top of the

agenda for many in the biotech industry, they delve into how SmartLabs has been

able to help companies build the best infrastructure for their needs – in a

market that is in a constant state of change.

In this episode Chris Walters, JLL’s Head of UK Life Sciences is joined by Harwell’s Stuart Grant, CEO and Dr Barbara Ghinelli, Director, Harwell Campus Business Development to discuss the future of Harwell Campus, the UK’s home for innovation. They delve into the importance of collaboration in creating connected clusters and how Harwell has successfully combined academia, businesses and government investment in one location to become a beacon of global science and discovery.

Travis McCready, Executive Director for US Life Sciences Markets at JLL joins our Head of Life Sciences, Dr Glenn Crocker in this episode to discuss the life sciences market in the United States and the impact that the global pandemic has had on the sector. 

Pete Wilder, Head of Property at Oxford Sciences Innovation (OSI) joins Chris Walters, Investor & Developer Life Sciences Lead in this episode to provide us with an inside view on the future of the Life Sciences market and its physical real estate needs. 

Matthew Jones, Partner at Hoare Lea joins Chris Walters, Investor & Developer Life Sciences Lead in this episode to debunk the myths within the life sciences sector. Matthew takes us through what is influencing design and engineering and the impact that the emerging innovation culture is having on the market.

Will the UK life sciences market ever catch up to the US? In this episode we are joined by Douglass Cuff, Vice President of UK Real Estate at IQHQ. We dive into the key drivers that propelled the US market and the opportunities within the UK. He joins Chris Walters to discuss these differences, as well as the ongoing impact COVID-19 is having on the short term and long term prospects for the life sciences industry.

Dr Glenn Crocker, Head of Life Sciences at JLL joins Chris Walters, Investor & Developer Life Sciences Lead to introduce Clustering Insights (our new podcast series) and discuss the impact and response to COVID-19 for investors and operators.

Rachel Dickie, Director of Urban Regeneration at Legal & General Capital joins Chris Walters, Investor & Developer Life Sciences Lead at JLL to discuss the future of the life sciences industry from their perspective as a funder, investor and developer. During this podcast Rachel explains why L&G’s purpose as a company has resulted in its commitment to the sector, promoting sustainable growth that benefits society and supports economic growth across the UK. Rachel also dives into the intrinsic link between regeneration and life sciences, which she believes will grow from strength to strength in the coming years.